PDPN and adenoma: For example, Nakayama et al. previously reported that 78% (50/65) of adenomas, 94% (30/32) of adenocarcinomas in situ, and 100% (8/8) of submucosally invasive adenocarcinomas had pericryptal PDPN expression [13].